DXB 1.47% 33.5¢ dimerix limited

Effectively there are no competitors - that is why the FDA has...

  1. 4,169 Posts.
    lightbulb Created with Sketch. 781
    Effectively there are no competitors - that is why the FDA has granted orphan status for Dimerix' DMX-200 combo (propagermanium+irbesartan).. Current standard of care is irbesartan, which is off-license (generic is available). Irbesartan was originally developed to treat high blood pressure I believe.
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
-0.005(1.47%)
Mkt cap ! $184.1M
Open High Low Value Volume
34.5¢ 34.5¢ 32.5¢ $746.7K 2.228M

Buyers (Bids)

No. Vol. Price($)
12 1061001 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 6228 1
View Market Depth
Last trade - 16.10pm 15/05/2024 (20 minute delay) ?
Last
34.0¢
  Change
-0.005 ( 0.35 %)
Open High Low Volume
34.0¢ 34.0¢ 33.0¢ 1458045
Last updated 15.59pm 15/05/2024 ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.